1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global MR-Linac Consumption Value by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 High-field MR-Linac
  • 1.3.3 Low-field MR-Linac
• 1.4 Market Analysis by Application
  • 1.4.1 Overview: Global MR-Linac Consumption Value by Application: 2021 Versus 2025 Versus 2032
  • 1.4.2 Prostate cancer
  • 1.4.3 Pancreatic cancer
  • 1.4.4 Liver cancer
  • 1.4.5 Lung cancer
  • 1.4.6 Others
• 1.5 Global MR-Linac Market Size & Forecast
  • 1.5.1 Global MR-Linac Consumption Value (2021 & 2025 & 2032)
  • 1.5.2 Global MR-Linac Sales Quantity (2021-2032)
  • 1.5.3 Global MR-Linac Average Price (2021-2032)

2 Manufacturers Profiles

• 2.1 Elekta AB
  • 2.1.1 Elekta AB Details
  • 2.1.2 Elekta AB Major Business
  • 2.1.3 Elekta AB MR-Linac Product and Services
  • 2.1.4 Elekta AB MR-Linac Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Elekta AB Recent Developments/Updates
• 2.2 ViewRay Systems, Inc.
  • 2.2.1 ViewRay Systems, Inc. Details
  • 2.2.2 ViewRay Systems, Inc. Major Business
  • 2.2.3 ViewRay Systems, Inc. MR-Linac Product and Services
  • 2.2.4 ViewRay Systems, Inc. MR-Linac Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.2.5 ViewRay Systems, Inc. Recent Developments/Updates
• 2.3 MagnetTx Oncology Solutions Ltd.
  • 2.3.1 MagnetTx Oncology Solutions Ltd. Details
  • 2.3.2 MagnetTx Oncology Solutions Ltd. Major Business
  • 2.3.3 MagnetTx Oncology Solutions Ltd. MR-Linac Product and Services
  • 2.3.4 MagnetTx Oncology Solutions Ltd. MR-Linac Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.3.5 MagnetTx Oncology Solutions Ltd. Recent Developments/Updates

3 Competitive Environment: MR-Linac by Manufacturer

• 3.1 Global MR-Linac Sales Quantity by Manufacturer (2021-2026)
• 3.2 Global MR-Linac Revenue by Manufacturer (2021-2026)
• 3.3 Global MR-Linac Average Price by Manufacturer (2021-2026)
• 3.4 Market Share Analysis (2025)
  • 3.4.1 Producer Shipments of MR-Linac by Manufacturer Revenue ($MM) and Market Share (%): 2025
  • 3.4.2 Top 3 MR-Linac Manufacturer Market Share in 2025
  • 3.4.3 Top 6 MR-Linac Manufacturer Market Share in 2025
• 3.5 MR-Linac Market: Overall Company Footprint Analysis
  • 3.5.1 MR-Linac Market: Region Footprint
  • 3.5.2 MR-Linac Market: Company Product Type Footprint
  • 3.5.3 MR-Linac Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global MR-Linac Market Size by Region
  • 4.1.1 Global MR-Linac Sales Quantity by Region (2021-2032)
  • 4.1.2 Global MR-Linac Consumption Value by Region (2021-2032)
  • 4.1.3 Global MR-Linac Average Price by Region (2021-2032)
• 4.2 North America MR-Linac Consumption Value (2021-2032)
• 4.3 Europe MR-Linac Consumption Value (2021-2032)
• 4.4 Asia-Pacific MR-Linac Consumption Value (2021-2032)
• 4.5 South America MR-Linac Consumption Value (2021-2032)
• 4.6 Middle East & Africa MR-Linac Consumption Value (2021-2032)

5 Market Segment by Type

• 5.1 Global MR-Linac Sales Quantity by Type (2021-2032)
• 5.2 Global MR-Linac Consumption Value by Type (2021-2032)
• 5.3 Global MR-Linac Average Price by Type (2021-2032)

6 Market Segment by Application

• 6.1 Global MR-Linac Sales Quantity by Application (2021-2032)
• 6.2 Global MR-Linac Consumption Value by Application (2021-2032)
• 6.3 Global MR-Linac Average Price by Application (2021-2032)

7 North America

• 7.1 North America MR-Linac Sales Quantity by Type (2021-2032)
• 7.2 North America MR-Linac Sales Quantity by Application (2021-2032)
• 7.3 North America MR-Linac Market Size by Country
  • 7.3.1 North America MR-Linac Sales Quantity by Country (2021-2032)
  • 7.3.2 North America MR-Linac Consumption Value by Country (2021-2032)
  • 7.3.3 United States Market Size and Forecast (2021-2032)
  • 7.3.4 Canada Market Size and Forecast (2021-2032)
  • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

• 8.1 Europe MR-Linac Sales Quantity by Type (2021-2032)
• 8.2 Europe MR-Linac Sales Quantity by Application (2021-2032)
• 8.3 Europe MR-Linac Market Size by Country
  • 8.3.1 Europe MR-Linac Sales Quantity by Country (2021-2032)
  • 8.3.2 Europe MR-Linac Consumption Value by Country (2021-2032)
  • 8.3.3 Germany Market Size and Forecast (2021-2032)
  • 8.3.4 France Market Size and Forecast (2021-2032)
  • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  • 8.3.6 Russia Market Size and Forecast (2021-2032)
  • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

• 9.1 Asia-Pacific MR-Linac Sales Quantity by Type (2021-2032)
• 9.2 Asia-Pacific MR-Linac Sales Quantity by Application (2021-2032)
• 9.3 Asia-Pacific MR-Linac Market Size by Region
  • 9.3.1 Asia-Pacific MR-Linac Sales Quantity by Region (2021-2032)
  • 9.3.2 Asia-Pacific MR-Linac Consumption Value by Region (2021-2032)
  • 9.3.3 China Market Size and Forecast (2021-2032)
  • 9.3.4 Japan Market Size and Forecast (2021-2032)
  • 9.3.5 South Korea Market Size and Forecast (2021-2032)
  • 9.3.6 India Market Size and Forecast (2021-2032)
  • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

• 10.1 South America MR-Linac Sales Quantity by Type (2021-2032)
• 10.2 South America MR-Linac Sales Quantity by Application (2021-2032)
• 10.3 South America MR-Linac Market Size by Country
  • 10.3.1 South America MR-Linac Sales Quantity by Country (2021-2032)
  • 10.3.2 South America MR-Linac Consumption Value by Country (2021-2032)
  • 10.3.3 Brazil Market Size and Forecast (2021-2032)
  • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

• 11.1 Middle East & Africa MR-Linac Sales Quantity by Type (2021-2032)
• 11.2 Middle East & Africa MR-Linac Sales Quantity by Application (2021-2032)
• 11.3 Middle East & Africa MR-Linac Market Size by Country
  • 11.3.1 Middle East & Africa MR-Linac Sales Quantity by Country (2021-2032)
  • 11.3.2 Middle East & Africa MR-Linac Consumption Value by Country (2021-2032)
  • 11.3.3 Turkey Market Size and Forecast (2021-2032)
  • 11.3.4 Egypt Market Size and Forecast (2021-2032)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

• 12.1 MR-Linac Market Drivers
• 12.2 MR-Linac Market Restraints
• 12.3 MR-Linac Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of MR-Linac and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of MR-Linac
• 13.3 MR-Linac Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 MR-Linac Typical Distributors
• 14.3 MR-Linac Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global MR-Linac market size was valued at US$ 733 million in 2025 and is forecast to a readjusted size of US$ 1357 million by 2032 with a CAGR of 10.0% during review period.
Magnetic resonance-guided radiation therapy system is a high-end tumor treatment equipment that deeply integrates magnetic resonance imaging (MR/MRI) with external beam radiation therapy devices, typically medical electronic linear accelerators, in both hardware and software.It aims to continuously acquire MR images with high soft-tissue contrast resolution before, during and even throughout treatment, and achieve more accurate dose delivery to tumors while better protecting surrounding normal tissues through online plan adaptation, real-time tracking and gating.In 2025, the global sales volume of MR-Linac was approximately 95 units, with an average price of about 7.5 million US dollars per unit, and the industry average gross profit margin stood at around 30%.
MR-Linac systems are evolving from "high-end demonstration equipment" to "capability platforms built around precision adaptive treatment". The focus of market competition is no longer merely the integration of imaging and radiotherapy hardware, but clinical workflow, online adaptive efficiency, motion management, physician team training, and hospital-wide collaboration capabilities. The current landscape is characterized by "dominance by a small number of system manufacturers, high entry barriers, and long verification cycles". On the one hand, accumulating clinical evidence and new product approvals are improving hospital acceptance; on the other hand, complex procedures, construction and operational difficulties still limit rapid popularization. Manufacturers that can simultaneously deliver robust treatment efficacy, efficiency and replicable deployment will have greater opportunities in the future.
This report is a detailed and comprehensive analysis for global MR-Linac market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global MR-Linac market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global MR-Linac market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global MR-Linac market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global MR-Linac market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for MR-Linac
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global MR-Linac market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Elekta AB, ViewRay Systems, Inc., MagnetTx Oncology Solutions Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
MR-Linac market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
High-field MR-Linac
Low-field MR-Linac
Market segment by Application
Prostate cancer
Pancreatic cancer
Liver cancer
Lung cancer
Others
Major players covered
Elekta AB
ViewRay Systems, Inc.
MagnetTx Oncology Solutions Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe MR-Linac product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of MR-Linac, with price, sales quantity, revenue, and global market share of MR-Linac from 2021 to 2026.
Chapter 3, the MR-Linac competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the MR-Linac breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and MR-Linac market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of MR-Linac.
Chapter 14 and 15, to describe MR-Linac sales channel, distributors, customers, research findings and conclusion.